These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6811232)

  • 1. Biological effects of bone-seeking alpha emitters with respect to the risk of internal contamination in man.
    Svoboda V; Sedlák A; Bubeníková D; Klener V
    Czech Med; 1982; 5(2):80-9. PubMed ID: 6811232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoblastoses in mice contaminated with low activities of 239Pu.
    Svoboda V; Bubeníková D
    Neoplasma; 1990; 37(6):639-46. PubMed ID: 2274084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation.
    Harrison JD; Muirhead CR
    Int J Radiat Biol; 2003 Jan; 79(1):1-13. PubMed ID: 12556326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late effects of 226Ra, 224Ra and 239Pu in female mice of the ICR strain.
    Kofránek V; Sedlák A; Bubeníková D; Dvorák V
    Strahlentherapie Sonderb; 1985; 80():88-92. PubMed ID: 3868210
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone sarcomas in 239Pu-treated mice.
    Svoboda V; Klener V; Bubeníková D; Globocnik E
    Neoplasma; 1980; 27(1):3-10. PubMed ID: 6929411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative toxicity of 226Ra, 239Pu, 241Am, 249Cf, and 252Cf in C57BL/Do black and albino mice.
    Taylor GN; Mays CW; Lloyd RD; Gardner PA; Talbot LR; McFarland SS; Pollard TA; Atherton DR; VanMoorhem D; Brammer D; Brammer TW; Ayoroa G; Taysum DH
    Radiat Res; 1983 Sep; 95(3):584-601. PubMed ID: 6611863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal hematological changes in mice bearing osteosarcomas induced by plutonium-239.
    Svoboda V; Klener V; Bubeníková D; Kotasková Z
    Neoplasma; 1980; 27(5):567-74. PubMed ID: 6939969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of the dosimetry of alpha-emitting radionuclides in bone with particular emphasis on 226Ra and 239Pu.
    Thorne MC
    Phys Med Biol; 1977 Jan; 22(1):36-46. PubMed ID: 265072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha particles are extremely damaging to developing hemopoiesis compared to gamma irradiation.
    Jiang TN; Lord BI; Hendry JH
    Radiat Res; 1994 Mar; 137(3):380-4. PubMed ID: 8146282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteosarcomas among beagles exposed to 239Pu.
    Whittemore AS; McMillan A
    Radiat Res; 1982 Apr; 90(1):41-56. PubMed ID: 6950452
    [No Abstract]   [Full Text] [Related]  

  • 11. The microdistribution and retention of injected 239Pu on trabecular bone surfaces of the beagle: implications for the induction of osteosarcoma.
    Wronski TJ; Smith JM; Jee WS
    Radiat Res; 1980 Jul; 83(1):74-89. PubMed ID: 6930688
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumorigenic target cell regions in bone marrow studied by localized dosimetry of 239Pu, 241Am and 233U in the mouse femur.
    Lord BI; Austin AL; Ellender M; Haines JW; Harrison JD
    Int J Radiat Biol; 2001 Jun; 77(6):665-78. PubMed ID: 11403706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mathematical model of the sarcomagenic action of osteotropic alpha emitters].
    Petoian IM; Filiushkin IV
    Radiobiologiia; 1985; 25(3):356-61. PubMed ID: 3860888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction by 239Pu of myeloid leukaemia and osteosarcoma in female CBA mice.
    Humphreys ER; Loutit JF; Stones VA
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Feb; 51(2):331-9. PubMed ID: 3493993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of osteosarcoma and acute myeloid leukaemia in CBA/H mice by the alpha-emitting nuclides, uranium-233, plutonium-239 and amercium-241.
    Ellender M; Harrison JD; Pottinger H; Thomas JM
    Int J Radiat Biol; 2001 Jan; 77(1):41-52. PubMed ID: 11213349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain differences in carcinogenic and hematopoietic responses of mice after injection of plutonium citrate.
    Oghiso Y; Yamada Y
    Radiat Res; 2000 Oct; 154(4):447-54. PubMed ID: 11023609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal change in microdosimetry to bone marrow and stromal progenitor cells from alpha-particle-emitting radionuclides incorporated in bone.
    Austin AL; Ellender M; Haines JW; Harrison JD; Lord BI
    Radiat Res; 1999 Dec; 152(6 Suppl):S38-42. PubMed ID: 10564934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of low-level 239Pu contamination on murine bone-marrow stem cells and their progeny.
    Svoboda V; Sedlák A; Kypĕnová H; Bubeníková D
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Oct; 52(4):517-26. PubMed ID: 3499406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of rat age and the quantity of plutonium administered to them on the development of osteosarcoma].
    Siniakov EG
    Radiobiologiia; 1976; 16(4):631-4. PubMed ID: 1069315
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteosarcoma risk after simultaneous incorporation of the long-lived radionuclide 227Ac and the short-lived radionuclide 227Th.
    Müller WA; Murray AB; Linzner U; Luz A
    Radiat Res; 1990 Jan; 121(1):14-20. PubMed ID: 2300664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.